PortalPublikationenEfficacy and safety of faldaprevir, deleobuvir, and ribaviri...

Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in Treatment-naive patients with chronic Hepatitis C Virus infection and advanced liver fibrosis or cirrhosis.

Standard

Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in Treatment-naive patients with chronic Hepatitis C Virus infection and advanced liver fibrosis or cirrhosis. / SOUND-C2 Study Group.

in: J ANTIMICROB CHEMOTH, Jahrgang 59, Nr. 2, 2015, S. 1282-1291.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

SOUND-C2 Study Group 2015, 'Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in Treatment-naive patients with chronic Hepatitis C Virus infection and advanced liver fibrosis or cirrhosis.', J ANTIMICROB CHEMOTH, Jg. 59, Nr. 2, S. 1282-1291. https://doi.org/10.1128/AAC.04383-14

APA

SOUND-C2 Study Group (2015). Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in Treatment-naive patients with chronic Hepatitis C Virus infection and advanced liver fibrosis or cirrhosis. J ANTIMICROB CHEMOTH, 59(2), 1282-1291. https://doi.org/10.1128/AAC.04383-14

Vancouver

SOUND-C2 Study Group. Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in Treatment-naive patients with chronic Hepatitis C Virus infection and advanced liver fibrosis or cirrhosis. J ANTIMICROB CHEMOTH. 2015;59(2):1282-1291. https://doi.org/10.1128/AAC.04383-14

Bibtex

@article{de302ffec3254a52a927c54930647432,
title = "Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in Treatment-naive patients with chronic Hepatitis C Virus infection and advanced liver fibrosis or cirrhosis.",
author = "Zeuzem Stefan and Vincente Soriano and Tarik Asselah and Gane, {Edward J.} and Jean-Pierre Bronowicki and Peter Angus and Lohse, {Ansgar Wilhelm} and Felix Stickel and Beat M{\"u}lhaupt and Stuart Roberts and Marcus Schuchmann and Michael Manns and Marc Bouli{\`e}re and Maria Buti and Stern, {Jerry O.} and John-Paul Gallivan and Florian Voss and Sabo, {John P.} and Wulf B{\"o}cher and Mensa, {Federico J.} and {SOUND-C2 Study Group}",
year = "2015",
doi = "10.1128/AAC.04383-14",
language = "English",
volume = "59",
pages = "1282--1291",
journal = "J ANTIMICROB CHEMOTH",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in Treatment-naive patients with chronic Hepatitis C Virus infection and advanced liver fibrosis or cirrhosis.

AU - Stefan, Zeuzem

AU - Soriano, Vincente

AU - Asselah, Tarik

AU - Gane, Edward J.

AU - Bronowicki, Jean-Pierre

AU - Angus, Peter

AU - Lohse, Ansgar Wilhelm

AU - Stickel, Felix

AU - Mülhaupt, Beat

AU - Roberts, Stuart

AU - Schuchmann, Marcus

AU - Manns, Michael

AU - Boulière, Marc

AU - Buti, Maria

AU - Stern, Jerry O.

AU - Gallivan, John-Paul

AU - Voss, Florian

AU - Sabo, John P.

AU - Böcher, Wulf

AU - Mensa, Federico J.

AU - SOUND-C2 Study Group

PY - 2015

Y1 - 2015

U2 - 10.1128/AAC.04383-14

DO - 10.1128/AAC.04383-14

M3 - SCORING: Journal article

VL - 59

SP - 1282

EP - 1291

JO - J ANTIMICROB CHEMOTH

JF - J ANTIMICROB CHEMOTH

SN - 0305-7453

IS - 2

ER -